SYNNEX Brings Commvault’s Cloud Data Protection Solutions

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SYNNEX Brings Commvault’s Cloud Data Protection Solutions to Managed Service Providers

ANAHEIM, Calif., Nov. 09, 2015 (GLOBE NEWSWIRE) -- (From the SYNNEX Varnex Fall Conference) – SYNNEX Corporation (NYSE: SNX ), a leading Technology Solutions distributor, has bolstered its Cloud strategy with the signing of Commvault , a leader in data protection and information management solutions. SYNNEX is the first to aggregate Commvault’s data management and cloud data protection solutions for SYNNEX’ MSP customers. Now with Commvault’s monthly-based usage licensing through SYNNEX, solution providers can build their own white label cloud data management solution, whether they install it in their own datacenters or a leased datacenter environment, such as Microsoft Azure. 

Commvault is one of the most comprehensive data management platforms of its kind, covering data protection, cloud infrastructure management, data retention and compliance. Commvault gives the solutions provider 100 percent control over all aspects of the data while reducing costs. Solution providers can also bill their end-user customers directly.

“As the proliferation of data moves at an exponential rate, solution providers need options not only to protect their customers’ data, but also to be able to manage it,” said Rob Moyer, Vice President, Cloud and Software Solutions, SYNNEX Corporation. “Commvault’s data protection solutions are an integral part of SYNNEX’s cloud portfolio. While suitable for any vertical, Commvault is especially beneficial for public sector where compliance with data retention is paramount.”

Through the next generation of Commvault’s market leading solutions portfolio, released in October, SYNNEX is able to deliver a broad spectrum of innovation to solution providers, helping their customers  address the increasing challenges of managing data and information in highly disrupted, fast-paced global business environments. 

“SYNNEX’s commitment and focus on managed and cloud service providers by offering value added services and solutions to these organizations enables Commvault to expand our reach to key customer markets through our leading data management portfolio,” said Todd Sommers, Area Vice President, Cloud Solutions Group, Commvault. “We look forward to building on this relationship for the best interests of our mutual customers as we gain momentum with our new integrated data management offering and the Commvault Data Platform.”

To learn more Commvault through SYNNEX, email commvault@synnex.com or contact your SYNNEX sales rep.

About SYNNEX

SYNNEX Corporation (NYSE: SNX ), a Fortune 500 corporation, is a leading business process services company, optimizing supply chains and providing outsourced services focused on customer relationship management. SYNNEX distributes a broad range of information technology systems and products, and also provides systems design and integration solutions. Concentrix, a wholly-owned subsidiary of SYNNEX Corporation, offers a portfolio of strategic solutions and end-to-end business services around customer engagement strategy, process optimization, technology innovation, front and back-office automation and business transformation to clients in ten identified industry verticals. Founded in 1980, SYNNEX Corporation operates in 25 countries around the world. Additional information about SYNNEX may be found online at www.synnex.com .

Safe Harbor Statement

Statements in this release that are forward-looking, such as platform and solution features and capabilities and the success of the collaboration, involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this release. The Company assumes no obligation to update any forward-looking statements contained in this release.

Copyright 2015 SYNNEX Corporation. All rights reserved. SYNNEX, the SYNNEX Logo, CONCENTRIX, and all other SYNNEX company, product and services names and slogans are trademarks or registered trademarks of SYNNEX Corporation. SYNNEX, the SYNNEX Logo and CONCENTRIX Reg. U.S. Pat. & Tm. Off. Other names and marks are the property of their respective owners. 

SNX-G

Media Contact: Amanda Long Account Director, Hughes Agency For SYNNEX Corporation (864) 271-0718 amandal@hughes-agency.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 8

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 9

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 6

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing $1000 in Lockheed Martin: A Decade of Growth

Updated Category News Views 91

Unlocking the Power of $1000: The Journey of Lockheed Martin Lockheed Martin has excelled in the stock market, delivering impressive returns for investors who bought shares a decade ago. With a current market capitalization of $138.10 billion, this defense powerhouse has consistently outperformed the market, achieving an annualized growth rate that surpasses expectations....

Continue Reading
Fortis Financial Performance Update: Q4 Earnings Insights

Updated Category News Views 169

Fortis Financial Performance Overview Fortis (NYSE: FTS) has recently shared its Q4 earnings results, revealing strong performance that is worth a closer look. The company's earnings announcement not only highlights its financial health but also offers insights for investors and stakeholders alike. Earnings Highlights In its latest announcement, Fortis exceeded earnings...

Continue Reading
Flowers Foods Increases Quarterly Dividend to $0.24 Per Share

Updated Category News Views 100

Flowers Foods Declares Increased Quarterly Dividend Flowers Foods, Inc. (NYSE: FLO) has recently taken significant steps in its financial directives by announcing a quarterly dividend of $0.24 per share. This marks a commendable increase of 4.3% compared to the same quarter last year. Impressively, this is the 90th consecutive quarterly dividend paid by the company....

Continue Reading
Freeport McMoRan Adjusts Copper Sales Amid Production Setbacks

Updated Category News Views 65

Freeport McMoRan to Delay Indonesian Copper Sales Freeport McMoRan, a significant player in the copper mining industry, has announced a postponement of its refined copper sales from Indonesia to the second quarter of 2025. This decision follows a fire incident at its new smelter, causing an unexpected delay in production. Production Challenges at Manyar Smelter The Manyar...

Continue Reading
Snowflake and Palantir: Revolutionizing AI in Data Management

Updated Category News Views 240

Understanding the Important Deal Between Snowflake and Palantir Snowflake Inc. (NYSE: SNOW) has recently entered a significant partnership with Palantir Technologies Inc. (NYSE: PLTR), marking an important milestone in its ambitious journey towards enhancing artificial intelligence (AI) capabilities for businesses. This collaboration aims to foster enterprise AI...

Continue Reading